Search Results for "Food And Drug Administration Philippines Mandates"

05:05 EST 8th February 2016 | BioPortfolio

Matching Channels

Jobs in Administration

Oral Administration

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

Food Allergy


Immunocore’s ImmTAC technology enables the immune system to recognise and kill cancer or viral cells. T Cell Receptors naturally recognise diseased cells and Immunocore’s competitive ad...

Matching News

Sanofi Pasteur's dengue vaccine Dengvaxia gets approval in Philippines

Sanofi Pasteur has received marketing approval from the Philippines' Food and Drug Administration for Dengvaxia to prevent all four dengue types in individuals aged from nine to 45 years and living in...

Sanofi Pasteur dengue vaccine approved for Philippines

A vaccine for the dengue virus developed by Sanofi Pasteur has been approved for use in the Philippines. The Philippine Food and Drug Administration has officially approved Dengvaxia to be ...

China Mandates Use Of Generic Names For All Medical Devices

The China Food and Drug Administration has finalized a new rule that will make it mandatory for all medtech companies to use only generic terms for naming medical devices being marketed in China.

U.S. Food And Drug Administration Approves Humulin R U-500 KwikPen

INDIANAPOLIS, Jan. 21, 2016 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's Humulin R U-500 KwikPen (insulin human injection) 500 units/mL, a pre-fille...

Sanofi collaborates with Iran Food and Drug Administration

French pharmaceutical firm Sanofi has signed a Memorandum of Cooperation (MoC) with the Iran Food and Drug Administration, affiliated to the Ministry of Health and Medical Education of Iran, in order ...

Food and Drug Administration approves Odomzo for treatment of basal cell carcinoma

The U. S. Food and Drug Administration approved Odomzo® (sonidegib, formerly LDE225) for the treatment of patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surge...

Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals Envarsus® XR Granted Orphan Drug Status by U.S. Food and Drug Administration for Kidney Transplant Rejection Prophylaxis

Company Announcement no. 18/2015 To: NASDAQ OMX Copenhagen A/S Hørsholm, Denmark, 14 August 2015 Veloxis Pharmaceuticals Envarsus® XR Granted Orphan Drug Status by U.S. Food and Drug Administration....

National Committee on Biosafety of the Philippines Celebrates 25th Anniversary

The National Committee on Biosafety of the Philippines celebrated its 25th founding anniversary, with the theme "Celebrating 25 years of Biosafety in the Philippines Looking Back…Moving Forward" at...

Matching PubMed Articles

Impact of a US Food and Drug Administration Drug Safety Communication on Zolpidem Dosing: An Observational Retrospective Cohort.

Zolpidem is a sedative-hypnotic widely prescribed in the United States. Recently, the US Food and Drug Administration (FDA) issued a drug safety communication regarding its dosing in women.

Use of data mining at the food and drug administration.

This article summarizes past and current data mining activities at the United States Food and Drug Administration (FDA).

Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.

To assess the relative frequency of reporting of adverse events involving ventricular arrhythmia, cardiac arrest, QTc prolongation, or torsade de pointes to the US Food and Drug Administration (FDA) b...

Pediatric registries at the Food and Drug Administration: design aspects that increase their likelihood of success.

To determine aspects of the design of pediatric registries that contribute to the success of registries conducted as a postmarketing study following approval of drugs or biological products by the US ...

Transvaginal mesh in the media following the 2011 US food and drug administration public health notification update.

Prompted by patients' changing perceptions of transvaginal mesh, this study examines how mesh has been reported in the news following the 2011 US Food and Drug Administration (FDA) updated notificatio...

Search Whole site using Google

Quick Search
Advertisement Advertisement